NEW YORK, NY, Canid, the healthcare technology company dedicated to streamlining pediatric vaccine management, today announced it has raised $10 million in Series A funding.
The round led by Telescope Partners with participation from FJ Labs, Brooklyn Bridge Ventures, SeedtoB and others. The investment, which brings Canid's total funding to $12.9 million, will fuel the company's expansion as it serves a growing number of independent pediatricians across the United States.
Canid is revolutionizing pediatric vaccine management by turning the complex and expensive process of giving a vaccine into a simple scan-and-go workflow. Canid's platform integrates directly with electronic health record systems and uses AI, software and economies of scale to drastically reduce the time and money pediatricians must spend on this crucial but burdensome process.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.